In an ambitious move to bridge the gap between regional oncology care and specialized academic medicine, San Francisco-based virtual cancer clinic Color has announced a significant expansion of its Expert Medical Opinion services. The new peer-to-peer program represents a fundamental shift in how complex cancer cases are managed within employer and health plan populations, moving away from static, one-time consultations toward a model of continuous, multidisciplinary oversight.
For decades, the “gold standard” of cancer care has been tethered to geographic proximity to National Cancer Institute (NCI)-designated cancer centers. By leveraging a national network of subspecialists and data-driven identification, Color aims to democratize this level of expertise, ensuring that patients—regardless of their location—receive high-level clinical guidance throughout their entire treatment journey.
The Core Facts: A New Model for Oncology
Color’s primary mission is to serve employers, health plans, unions, and the public sector by providing a comprehensive cancer care continuum. The organization assists in identifying high-risk members, performing screenings, managing active clinical treatment, and providing long-term support for survivors.
The centerpiece of this recent announcement is the expansion of the Expert Medical Opinion program. Historically, Color provided multidisciplinary reviews only to patients already enrolled in its program. With the launch of the new peer-to-peer service, the company is breaking down those silos. Using claims and prior authorization data, Color can now proactively identify complex, high-risk cancer cases across an entire health plan or employer population—even for patients who have not yet signed up for Color’s direct care services.
Once a complex case is identified, Color’s specialists engage directly with the patient’s local oncologist. This peer-to-peer consultation is not merely an advisory note; it is designed to be an active, collaborative partnership. The goal is to provide local providers with the insights of NCI-level subspecialists, ensuring that diagnostic reviews, tumor boards, and treatment evaluations are informed by the latest clinical data.
A Chronology of Innovation in Virtual Care
To understand the significance of this expansion, one must look at the evolution of Color Health’s operational model:
- Early Foundations: Color began its journey as a provider of genetic testing and population health services, identifying risks before they manifested as disease.
- The Pivot to Cancer Care: Recognizing the fragmentation in the oncology space, the company transitioned into a full-scale virtual cancer clinic. This involved building a 50-state medical group capable of delivering clinical care across state lines.
- The “Expert Opinion” Era: The initial iteration of the Expert Medical Opinion program offered patients a formal second look at their diagnoses. However, internal data suggested that a “snapshot” approach was insufficient for the evolving nature of cancer.
- 2025 – The Peer-to-Peer Expansion: The company identified that the greatest bottleneck in oncology wasn’t just a lack of second opinions, but a lack of coordination between local providers and top-tier subspecialists. By integrating claims data with proactive clinical outreach, Color has now evolved from a reactive service provider to an active participant in clinical decision-making.
Supporting Data: Why the Model Works
The impetus for this expansion is rooted in hard data. Color’s internal analysis of its Expert Medical Opinion service reveals two critical metrics that highlight the necessity of this shift:
- Clinical Impact: Approximately 95% of patients who utilized the service received at least one recommended change in their care plan. This suggests that the “standard” local treatment path is frequently optimized when reviewed by a multidisciplinary team of subspecialists.
- Economic Efficiency: By optimizing care plans early, avoiding unnecessary or redundant treatments, and managing toxicities before they lead to emergency interventions, the program has generated an estimated $62,000 in average cost savings per patient.
These figures illustrate a rare alignment in healthcare: better clinical outcomes directly correlate with significant financial savings. By intervening at the “decision point,” Color is preventing the costly, downstream complications that often arise from sub-optimal treatment paths.
Official Perspectives: Redefining the Patient Journey
Caroline Savello, president of Color Health, has been the primary architect of this new approach. In recent statements, she emphasized the philosophical shift required to improve cancer outcomes.
“While a traditional second opinion is one consultation with one expert at one point in time, cancer is always evolving,” Savello noted. “Diagnoses progress, treatments change, toxicities emerge, and clinical trials open and close. What patients actually need is ongoing, multidisciplinary review from a team that knows their case and has the authority to act on what it finds.”
Savello points to the structural barriers that have historically kept this level of care exclusive. “That has historically only been available to a small fraction of patients with the rarest and most complex cases, largely because convening a panel of subspecialists requires high cost, coordination, and proximity to a major academic center.”
By leveraging technology and a nationwide network of specialists—including experts in breast cancer, gastrointestinal cancers, gynecologic oncology, cancer genetics, cardio-oncology, and palliative care—Color is effectively digitizing the “tumor board” experience.
“What we’re offering goes well past a second opinion,” Savello added. “A second opinion is a snapshot. What Color provides is an ongoing, expert-informed, multidisciplinary partnership for the entire treatment journey. Our clinical team holds a real relationship with the patient and the provider, and we’re empowered to act on what we find.”
Implications for the Healthcare Landscape
The expansion of Color’s peer-to-peer service carries profound implications for the future of oncology and employer-sponsored health benefits.
1. The Death of the “Snapshot” Consultation
The healthcare industry is moving away from episodic care. As cancer treatments become increasingly personalized—incorporating genomic profiling and precision medicine—a single diagnostic review is insufficient. Color’s model signals a shift toward “living” treatment plans that are continuously updated by multidisciplinary teams.
2. Empowering the Local Provider
One of the most significant aspects of this model is that it does not attempt to replace the patient’s local oncologist. Instead, it serves as a force multiplier. By providing local physicians with access to NCI-designated experts, Color helps reduce the “knowledge gap” that often exists between community-based oncology practices and massive research hospitals. This allows patients to receive world-class expertise without the burden of traveling for every consultation.
3. Data-Driven Proactivity
The use of claims and prior authorization data to trigger clinical intervention represents a sophisticated use of health tech. By identifying high-risk cases before a crisis occurs, Color is moving the needle from reactive treatment to proactive, preventative clinical management. This is a critical development for health plans and employers who are looking to manage the skyrocketing costs of cancer care without sacrificing the quality of life for their members.
4. Narrowing the Equity Gap
Perhaps the most important implication is the potential for improved health equity. Historically, access to top-tier oncological subspecialists has been determined by socioeconomic status and geography. By wrapping this expertise into a virtual, employer-sponsored benefit, Color is effectively leveling the playing field for employees who might otherwise have had no access to academic-level tumor boards.
Conclusion: The New Rule of Care
The goal for Color is clear: to make ongoing, multidisciplinary care the standard of oncology rather than a luxury reserved for a privileged few. By evolving its service to be more proactive, collaborative, and continuous, Color is challenging the traditional, fragmented approach to cancer care.
As the industry watches, the success of this peer-to-peer expansion may serve as a blueprint for other specialties. In a world where medical information is expanding faster than any single physician can keep up with, the model of “expert-informed partnership” may well be the future of modern medicine. For patients currently navigating the complexities of a cancer diagnosis, this evolution in care offers something more valuable than a second opinion—it offers a consistent, expert-backed partner in their fight for health.
